FDA has cleared Spectranetics’ new line of devices designed to treat clogged leg arteries. The Turbo elite products will be launched in limited release during the fourth quarter, and fully released in early 2007.
The devices are used in conjunction with the company’s excimer laser system, which helps open clogged or obstructed arteries. Spectranetics, Colorado Springs, CO, is a manufacturers of lasers used to treat heart conditions.
June 13, 2026 — New research shows that infrainguinal endovascular interventions for peripheral artery disease (PAD) ...
June 15, 2026 
June 10, 2026 — New research shows that patients with peripheral artery disease (PAD) who adhere to pre-operative ...
June 11, 2026 
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...
September 12, 2025 
June 6, 2025 – A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 ...
June 06, 2025 
Feb. 3, 2025 — Today, Peripheral Artery Disease (PAD) affects 10 million Americans and is the most common cause of limb ...
February 04, 2025 
Jan. 13, 2025 – R3 Vascular Inc., a medical device company dedicated to treating peripheral arterial disease (PAD) ...
January 13, 2025 
A new study reports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more ...
January 13, 2025 
Dec. 13, 2024 – Sensome has announced positive results from two studies of its Clotild Smart Guidewire System ...
December 16, 2024 
Nov. 18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with ...
December 03, 2024 
Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...
November 08, 2024 